BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23711811)

  • 1. Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction.
    Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Jeong DS; Sung K; Kim WS; Lee YT; Gwon HC
    Am J Cardiol; 2013 Sep; 112(5):623-9. PubMed ID: 23711811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.
    Wu X; Chen Y; Liu H; Teirstein PS; Kirtane AJ; Ge C; Song X; Chen X; Gu C; Huang F; Lv S
    Am J Cardiol; 2010 Jun; 105(12):1728-34. PubMed ID: 20538122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
    Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
    Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization.
    Kim YG; Park DW; Lee WS; Park GM; Sun BJ; Lee CH; Hwang KW; Cho SW; Kim YR; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Han S; Jung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Am J Cardiol; 2012 Jun; 109(11):1548-57. PubMed ID: 22425329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry).
    Leitner J; Vlachos HA; Selzer F; Jamal SM; Kip KE; Williams DO; Abbott JD
    Am J Cardiol; 2012 Feb; 109(4):466-70. PubMed ID: 22118825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of drug eluting stent implantation with coronary artery bypass surgery in the treatment of patients with chronic total occlusion and multiple vessel disease.
    Liu W; Ma CS; Kang JP; Du X; Chen F; Zhou YJ; Lü SZ; Huang FJ; Gu CX; Zhu XL
    Chin Med J (Engl); 2011 Apr; 124(8):1169-74. PubMed ID: 21542990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention in patients with previous coronary artery bypass grafting (from the j-Cypher Registry).
    Yamaji K; Kimura T; Morimoto T; Nakagawa Y; Inoue K; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2013 Oct; 112(8):1110-9. PubMed ID: 23827399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of complete versus incomplete revascularization for patients with multivessel coronary artery disease and left ventricular systolic dysfunction in drug-eluting stent era.
    Sohn GH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Gwon HC; Lee SH
    J Korean Med Sci; 2014 Nov; 29(11):1501-6. PubMed ID: 25408581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
    Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
    Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
    Kang SH; Lee CW; Baek S; Lee PH; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2017 Jul; 120(1):69-74. PubMed ID: 28483202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.